Compounded Bioidentical Hormone Therapy Market Trends

  • Report ID: 4088
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Compounded Bioidentical Hormone Therapy Market Trends

Growth Drivers  

  • Rising Awareness Amongst People
  • Increasing Cases of Thyroid, Insulin Resistance, and Osteoporosis  

Challenges 

  • Associated Health Hazards with Hormone Therapy

Compounded Bioidentical Hormone Therapy Market: Key Insights

Healthcare Expenditure per Capita, (USD), 2015-2018

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centres for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Base Year

2024

Forecast Year

2025-2037

CAGR

5.2%

Base Year Market Size (2024)

Forecast Year Market Size (2037)

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4088
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The compounded bioidentical hormone therapy industry size is expected to register around 5.2% CAGR during the forecast period i.e., between 2025-2037.

The market growth is propelled by increasing health awareness amongst the people.

North America industry is expected to account for largest revenue share by 2037, on the back of higher healthcare expenditure, increasing thyroid prevalence amongst women, and more awareness amongst the people.

The major players in the market are Defy Medical, LLC, The biostation, Noven Pharmaceuticals, Inc., Novartis AG, and Pfizer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample